Rifampicin for continuation phase tuberculosis treatment in Uganda: a cost-effectiveness analysis.

<h4>Background</h4>In Uganda, isoniazid plus ethambutol is used for 6 months (6HE) during the continuation treatment phase of new tuberculosis (TB) cases. However, the World Health Organization (WHO) recommends using isoniazid plus rifampicin for 4 months (4HR) instead of 6HE. We compare...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Yukari C Manabe, Sabine M Hermans, Mohammed Lamorde, Barbara Castelnuovo, C Daniel Mullins, Andreas Kuznik
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2012
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c758d8673f4d471f8d969bb25ba89a2b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!